[1]康 凯,郑继伟,王 闰.糖皮质激素治疗甲亢伴浸润性突眼的疗效分析[J].医学信息,2018,31(08):103-104.[doi:10.3969/j.issn.1006-1959.2018.08.033]
　KANG Kai,ZHENG Ji-wei,WANG Run.Efficacy of Glucocorticoids in the Treatment of Hyperthyroidism with Infiltrating Exophthalmos[J].Journal of Medical Information,2018,31(08):103-104.[doi:10.3969/j.issn.1006-1959.2018.08.033]
点击复制

糖皮质激素治疗甲亢伴浸润性突眼的疗效分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
103-104
栏目:
临床研究
出版日期:
2018-04-15

文章信息/Info

Title:
Efficacy of Glucocorticoids in the Treatment of Hyperthyroidism with Infiltrating Exophthalmos
文章编号:
1006-1959（2018）08-0103-02
作者:
康 凯; 郑继伟; 王 闰
佳木斯市中心医院眼科，黑龙江 佳木斯 154002
Author(s):
KANG Kai; ZHENG Ji-wei; WANG Run
Department of Ophthalmology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
糖皮质激素; 甲亢; 浸润性突眼
Keywords:
Key words：Glucocorticoid; Hyperthyroidism; Infiltrating exophthalmos
分类号:
R581.1
DOI:
10.3969/j.issn.1006-1959.2018.08.033
文献标志码:
A
摘要:
目的 分析使用糖皮质激素分期治疗甲亢伴浸润性突眼的的临床疗效和不良反应发生率。方法 选取自2015年5月30日~2017年4月30日来我院接受治疗的甲亢伴浸润性突眼的患者64例，随机分为观察组和对照组，每组32例。对照组采用常规131I进行传统治疗，观察组采用糖皮质激素治疗，对比两组患者的疗效和不良反应发生率。结果 观察组总有效率为93.75%，高于对照组的68.75%，差异具有统计学意义（P＜0.05）。观察组不良反应发生率为71.88%，高于对照组的15.63%，差异具有统计学意义（P＜0.05）。结论 应用糖皮质激素治疗甲亢伴浸润性突眼症，能够从一定程度上大幅度缩短治疗时间，但是其不良反应过于剧烈，使患者在治疗方面获得一定的不良体验。
Abstract:
Abstract：Objective To analyze the clinical efficacy and incidence of adverse reactions in the treatment of hyperthyroidism with infiltrating exophthalmos using glucocorticoids.Methods 64 patients with hyperthyroidism and infiltrating exophthalmos who were treated in our hospital from May 30,2015 to April 30,2017 were randomly divided into observation group and control group,with 32 cases in each group.In the control group,conventional 131I was used for traditional treatment,and observation group was treated with glucocorticoids.The efficacy and incidence of adverse reactions were compared between the two groups.Results The total effective rate was 93.75% in the observation group,which was higher than 68.75% in the control group,the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was 71.88%,which was higher than that in the control group 15.63%,the difference was statistically significant(P<0.05).Conclusion Treatment of hyperthyroidism with infiltrating exophthalmos with glucocorticoids can shorten the treatment time to a certain extent,but the adverse reactions are too severe,so that patients receive certain adverse experiences in the treatment.

参考文献/References:

[1]张亚萍,赵明利,黄克斌,等.甲亢眼病大剂量糖皮质激素冲击加免疫抑制剂治疗疗效及不良反应的临床研究[J].西北国防医学杂志,2012,33(1):23-25.
[2]徐海燕,邵迎新.甲状腺功能亢进症的药物应用[J].中国医药导报,2011,8(34):11-12,34.
[3]曹雯,郑仁东,刘超.甲状腺机能亢进症合并胫前黏液性水肿的诊治进展[J].江苏医药,2017,43(12):877-879.
[4]姚晓波,张然,金晓毛,等.超声检查甲状腺功能亢进症伴有甲状腺结节患者的临床特点和131碘治疗效果分析[J].中国临床保健杂志,2017,20(4):404-407.
[5]贺冶冰,石少敏.Graves眼病的临床诊断和治疗进展[J].内科急危重症杂志,2011,17(2):69-71.

相似文献/References:

[1]钟时嘉.亚急性甲状腺炎的临床分析[J].医学信息,2018,31(01):181.[doi:10.3969/j.issn.1006-1959.2018.01.073]
　ZHONG Shi-jia.Clinical Analysis of Subacute Thyroiditis[J].Journal of Medical Information,2018,31(08):181.[doi:10.3969/j.issn.1006-1959.2018.01.073]
[2]唐培渊,宋俊峰,秦克乐,等.难治性特发性血小板减少性紫癜的治疗进展[J].医学信息,2018,31(05):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
　TANG Pei-yuan,SONG Jun-feng,QIN Ke-le,et al.Progress in Treatment of Refractory Idiopathic Thrombocytopenic Purpura[J].Journal of Medical Information,2018,31(08):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
[3]苗艳茹.甲巯咪唑与糖皮质激素联合治疗甲状腺功能亢进症合并症的效果分析[J].医学信息,2018,31(05):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
　MIAO Yan-ru.Analysis of Effects of Methimazole and Glucocorticoids on Complications of Hyperthyroidism[J].Journal of Medical Information,2018,31(08):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
[4]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
　ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(08):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[5]孙清林.放射性核素131I在甲亢治疗中的安全性与有效性分析[J].医学信息,2018,31(15):120.[doi:10.3969/j.issn.1006-1959.2018.15.038]
　SUN Qing-lin.Safety and Efficacy Analysis of Radionuclide 131I in the Treatment of Hyperthyroidism[J].Journal of Medical Information,2018,31(08):120.[doi:10.3969/j.issn.1006-1959.2018.15.038]
[6]刘广涛,关凤军,董 晨.原发性肾病综合征患儿肾组织P-gp170蛋白和mRNA表达与临床病理及预后的关系[J].医学信息,2018,31(21):61.[doi:10.3969/j.issn.1006-1959.2018.21.017]
　LIU Guang-tao,GUAN Feng-jun,DONG Chen.Relationship between the Expression of p-gp170 Protein and mRNA in Renal Tissue of Children with Primary Nephrotic Syndrome and Clinical Pathology and Prognosis[J].Journal of Medical Information,2018,31(08):61.[doi:10.3969/j.issn.1006-1959.2018.21.017]
[7]陈晓霞,唐 勇,胡 庆,等.吗替麦考酚酯联合糖皮质激素治疗特发性膜性肾病的疗效观察[J].医学信息,2018,31(22):89.[doi:10.3969/j.issn.1006-1959.2018.22.024]
　CHEN Xiao-xia,TANG Yong,HU Qing,et al.Therapeutic Effect of Mycophenolate Mofetil Combined with Glucocorticoid on Idiopathic Membranous Nephropathy[J].Journal of Medical Information,2018,31(08):89.[doi:10.3969/j.issn.1006-1959.2018.22.024]
[8]高 鹏,高 浩,燕 飞.坏疽性脓皮病1例[J].医学信息,2019,32(01):191.[doi:10.3969/j.issn.1006-1959.2019.01.063]
[9]马艳艳,刘建军.肌无力危象的治疗研究进展[J].医学信息,2019,32(06):45.[doi:10.3969/j.issn.1006-1959.2019.06.016]
　MA Yan-yan,LIU Jian-jun.Progress in the Treatment of Myasthenia Crisis[J].Journal of Medical Information,2019,32(08):45.[doi:10.3969/j.issn.1006-1959.2019.06.016]
[10]谢卫强,巩 栋,高明暄,等.关节病性银屑病伴髋关节结核1例[J].医学信息,2019,32(07):189.[doi:10.3969/j.issn.1006-1959.2019.07.062]

更新日期/Last Update: 2018-04-15